ROSWELL PARK CANCER INSTITUTE CORP
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication is a funding opportunity from ROSWELL PARK CANCER INSTITUTE CORP, up to 640437, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
Pediatric nonadherence to medication is a significant public health problem, and rigorous research repeatedly documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and death. Participants in our previous studies have described medication adherence as “one of the most…